These findings were replicated in MS brains through quantitative reverse transcription-polymerase chain reaction (RT-PCR) assay, showing that mRNA encoding CD20 (MS4A1) is constitutively expressed by brain CD8+ TRM cells [31]. This evidence concerns the gene MS4A1 and myeloid sarcoma.